ADAM10 Proteases and Pancreatic Cancer
Journal Title: Pancreas – Open Journal - Year 2016, Vol 1, Issue 2
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer-related deaths in the United States and is expected to rise to the second rank by 2020.1 The survival rate of PDAC is estimated at less than 5% and the high mortality rate is attributed to the asymptomatic progression and aggressive nature of the tumor, which exhibit locally advanced or metastatic disease at the time of diagnosis. Majority of the pancreatic cancers are PDACs and are characterized by a fibrotic tumor stroma.
Authors and Affiliations
Jaya Padmanabhan
Keywords
Related Articles
- EP ID EP556679
- DOI 10.17140/POJ-1-e003
- Views 181
- Downloads 0
Ultrasound Ablation in Advanced Pancreatic Cancer Patients – What should be the Next Step?
In the last decades the treatment for many diseases has changed dramatically. Open surgery procedures with high morbidity and complication rates, suboptimal clinical results based on large impairment for the patients wer...
Genetic Therapy for Pancreatic Cancer: Is it the Future?
Although surgery is still the only curative therapy for pancreatic cancer, oncological therapies have started to be more and more promising. We firstly have to consider two important points. The first one is that surgery...
Evaluation of the Best Power Setting of Laser Waves in Pancreatic Surgery: ECHO ND-YAG Laser Ablation on Bovine Pancreatic Tissue
Background: Pancreatic surgery is one of the most difficult and life-threatening surgical therapy especially during necrotizing pancreatitis and advanced solid neoplasms. Aim of the study: To evaluate the possibility to...
Pancreas: Do All Roads Lead to Mitochondria?
Over several millions of years of evolution, mitochondria have transformed into specialized organelles. Today, they cannot live outside the cell nor can the host cell live without them, resulting in a symbiotic relations...
Recurrent Acute Pancreatitis: Dangerous Etiology?
Acute pancreatitis (AP) is a disorder clinically characterized by upper abdominal pain and elevated levels of pancreatic enzymes in the blood.1 After an initial evaluation, up to 10-30% of patients with AP are diagnosed...